JOYCE SHEDRICK: Open Payments
NPI 1750866414 · PASADENA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 27 payments from 7 companies in 2025. Trend: 2023 $1,570 · 2024 $699 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $294 |
| ABBVIE INC. | 12 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
Products named: TREMFYA, RINVOQ, SKYRIZI, CREON, ENTYVIO, Wegovy, LINZESS, RELISTOR.
Industry payments across TX — which companies pay providers there.
